Campaign Data Sample Clauses

Campaign Data. During its performance under this Agreement, Company may disclose to Advertiser (i) certain aggregated and/or real-time reporting data on Model(s) performance and campaign delivery and/or (ii) data provided via Company’s secure model-building environment (collectively, “Campaign Data”). Campaign Data shall include any information derived from, or reverse-engineered from, aggregated reporting data on Model(s) performance and campaign delivery disclosed to Advertiser. Advertiser hereby agrees, with respect to Campaign Data:
Sample 1Sample 2
AutoNDA by SimpleDocs
Campaign Data. As used herein, “Campaign Data” means all data derived from Company’s use of the Service, but expressly excludes all Impression Attribute Data (except where Company wins the Bid for the inventory to which such Impression Attribute Data relates).Company shall have the right to use all Campaign Data for any lawful purpose that is consistent with its posted privacy policy, except that Company may not use Campaign Data to target across other advertising platforms, exchanges or inventory sources. Company acknowledges and agrees that PulsePoint shall have the right to use and disclose Campaign Data solely for the following purposes: (a) as part of PulsePoint’s business operations, provided that any disclosure shall be on an aggregate basis and in a manner such that the Campaign Data is not attributable to Company, (b) to perform its obligations under this Agreement, (c) to operate, manage, test, maintain and improve the PulsePoint RTB Service, including without limitation the scheduling and optimization of delivery of Advertisements across the PulsePoint Ad Exchange, (d) to protect the Service from what, in PulsePoint’s reasonable determination is a threat to the Service or PulsePoint Ad Exchange, (e) if required by court order or Law or required or requested by any governmental agency, and/or (f) as otherwise expressly authorized by Company.
Sample 1
Campaign Data. As between the Parties, Campaign owns all right, title and interest in and to any telephone numbers, names, notes or messages that are uploaded, received, stored, maintained, collected, or processed within GOP Envoy by Campaign(the “Campaign Data”). Subject to the provisions of Section 1.2(b), above, GOP Envoy shall have the non-revocable right to collect and store any such Campaign Data pursuant to GOP Envoy’s Privacy Policy (which is available at: xxxxx://xxx.xxxx.xxx/gop-envoy-privacy-policy/).
Sample 1
Campaign Data. Advertiser hereby grants to CMG the right to place tags, pixels, gifs or other means of collecting behavioral data and data regarding optimization and performance, including without limitation impressions, click-through rates and other metrics to assess the usage, traffic and effectiveness of the Advertiser Content (“Tags & Pixels”) within (a) the Advertiser Content, (b) the Advertiser websites or digital properties referenced in the Advertiser Content, or (c) other Advertiser websites or digital properties specified in an Order. CMG may, to the extent it deems appropriate, collect and compile certain non-personally identifiable information about user traffic and the delivery of the Advertiser Content (“Campaign Data”). Campaign Data may include advertising impressions served to and Advertising Content and Advertiser website content accessed by users. Campaign Data shall be the property of CMG and shall be deemed to be the Proprietary Information of CMG. Without limiting the foregoing, CMG may use and disclose the Campaign Data (i) for reporting purposes that may be subsequently provided to Advertiser as well as, in aggregate form, to potential customers and other third parties, including without limitation for the purpose of indexing Campaign Data against third party data sources to identify target audiences for Advertiser Content and Advertiser websites; (ii) if required by any court order, law or governmental entity; and (iii) for other CMG business purposes. For the avoidance of doubt, CMG will not use Campaign Data that is comprised solely of profiles of visitors to Advertiser’s website(s) to retarget a visitor for a purpose other than performing the Services; provided, however, that the foregoing limitation does not limit CMG from repurposing aggregated Campaign Data for any purpose, so long as it is not joined with data that is specific to or allows identification of Advertiser’s website. Likewise, CMG will not sell or otherwise disclose Advertiser- specific profile data to any third party or Affiliate, except as and to the extent necessary to perform its obligations under the applicable Order.
Sample 1

Related to Campaign Data

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • CUSTOMER SERVICE FUNCTIONS The Servicer shall handle all Customer inquiries and other Customer service matters according to the same procedures it uses to service Customers with respect to its own charges.

  • Customer Relations A. Actively promote DCP Holding Company in all Marketing, Sales, Public Relations, and Community activity.

  • Customer Service A. PRIMARY ACCOUNT REPRESENTATIVE. Supplier will assign an Account Representative to Sourcewell for this Contract and must provide prompt notice to Sourcewell if that person is changed. The Account Representative will be responsible for: • Maintenance and management of this Contract; • Timely response to all Sourcewell and Participating Entity inquiries; and • Business reviews to Sourcewell and Participating Entities, if applicable.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Review Systems; Personnel It will maintain business process management and/or other systems necessary to ensure that it can perform each Test and, on execution of this Agreement, will load each Test into these systems. The Asset Representations Reviewer will ensure that these systems allow for each Review Receivable and the related Review Materials to be individually tracked and stored as contemplated by this Agreement. The Asset Representations Reviewer will maintain adequate staff that is properly trained to conduct Reviews as required by this Agreement.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • TECHNICAL SUPPORT SERVICES 2.1 The technical support services (the "Services"): Party A agrees to provide to Party B the relevant services requested by Party B, which are specified in Exhibit 1 attached hereto ("Exhibit 1").

  • Technical Specifications The Technical Specifications furnished on the CD are intended to establish the standards for quality, performance and technical requirements for all labor, workmanship, material, methods and equipment necessary to complete the Work. When specifications and drawings are provided or referenced by the County, these are to be considered part of the Scope of Work, and to be specifically documented in the Detailed Scope of Work. For convenience, the County supplied specifications, if any, and the Technical Specifications furnished on the CD.

  • Quality Assurance The parties endorse the underlying principles of the Company’s Quality Management System, which seeks to ensure that its services are provided in a manner which best conforms to the requirements of the contract with its customer. This requires the Company to establish and maintain, implement, train and continuously improve its procedures and processes, and the employees to follow the procedures, document their compliance and participate in the improvement process. In particular, this will require employees to regularly and reliably fill out documentation and checklists to signify that work has been carried out in accordance with the customer’s specific requirements. Where necessary, training will be provided in these activities.

Time is Money Join Law Insider Premium to draft better contracts faster.